In yesterday’s Wall Street session, GoodRx Holdings Inc (NASDAQ:GDRX) shares traded at $8.06, up 10.87% from the previous session.
GDRX stock price is now 15.84% away from the 50-day moving average and 26.54% away from the 200-day moving average. The market capitalization of the company currently stands at $3.02B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $10, Raymond James recently Upgraded its rating from Mkt Perform to Outperform for GoodRx Holdings Inc (NASDAQ: GDRX). On April 10, 2024, KeyBanc Capital Markets Upgraded its previous ‘Sector Weight’ rating to ‘Overweight’ on the stock keeping its target price maintained at $9, while ‘Wells Fargo’ rates the stock as ‘Overweight’
In other news, Wagner Scott, insider bought 21,652 shares of the company’s stock on Nov 30 ’23. The stock was bought for $124,806 at an average price of $5.76. Upon completion of the transaction, the insider now directly owns 182,900 shares in the company, valued at $1.47 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 29 ’23, Wagner Scott bought 26,348 shares of the business’s stock. A total of $155,482 was incurred on buying the stock at an average price of $5.90. This leaves the insider owning 161,248 shares of the company worth $1.3 million. A total of 79.32% of the company’s stock is owned by insiders.
During the past 12 months, GoodRx Holdings Inc has had a low of $4.14 and a high of $9.37. As of last week, the company has a debt-to-equity ratio of 1.13, a current ratio of 6.29, and a quick ratio of 6.29.
According to the Health Information Services Company, earnings per share came in at 0.07, beating analysts’ expectations of 0.06 by 0.01. This compares to -$0.01 EPS in the same period last year. The net profit margin was -0.86% and return on equity was -0.90% for GDRX. The company reported revenue of $197.88 million for the quarter, compared to $183.99 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.55 percent. For the current quarter, analysts expect GDRX to generate $200.44M in revenue.
